Physician profile
Mariah White
NPI 1659731529
$9,668.07
in general payments reported to CMS, 2019-2025
49 companies · $728 in 2025
The $728 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,747 · 2022: $2,219 · 2023: $2,192 · 2024: $2,783 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,542 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,542.35 |
| Education | $160.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,338.96 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $870.97 | 2021-2025 | |
| Lilly USA, LLC | $666.25 | 2021-2024 | Emgality, Amyvid, Reyvow |
| Pfizer INC. | $643.58 | 2023-2025 | |
| Ucb, INC. | $581.61 | 2021-2024 | Briviact, Fintepla, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $487.58 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Neurelis, INC. | $361.14 | 2023-2025 | Valtoco |
| Acadia Pharmaceuticals INC | $320.22 | 2022-2024 | Nuplazid |
| Sk Life Science, INC. | $308.81 | 2022-2024 | |
| Genzyme Corporation | $285.93 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $260.86 | 2021-2023 | Ponvory |
| E.R. Squibb & Sons, L.L.C. | $245.46 | 2022-2023 | Zeposia |
| Biogen, INC. | $218.21 | 2021-2024 | Spinraza |
| Supernus Pharmaceuticals, INC. | $188.85 | 2021-2024 | Qelbree |
| Neurocrine Biosciences, INC. | $181.41 | 2022-2024 | Ingrezza, Ongentys |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariah White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.